HUB Investment Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Buy
1,735
+50
+3% +$9.56K 0.01% 879
2026
Q1
$309K Buy
+1,685
New +$310K 0.01% 794
2024
Q1
Sell
-843
Closed -$218K 486
2023
Q4
$218K Buy
+843
New +$207K 0.01% 368

Other funds holding BIIB

HUB Investment Partners's BIIB Position: Q2 2026 in Review

HUB Investment Partners increased its Biogen (BIIB) stake by 3% in Q2 2026, buying an estimated $9.56K and bringing the position to 1,735 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #879.

HUB Investment Partners first reported a position in BIIB in Q4 2023 and has held it in 3 quarters since. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • HUB Investment Partners held 1,735 shares of Biogen worth $375K as of Q2 2026.
  • HUB Investment Partners bought 50 Biogen shares in Q2 2026, an estimated $9.56K.
  • Biogen made up 0.01% of HUB Investment Partners's portfolio in Q2 2026, its #879 holding.
  • HUB Investment Partners first reported a position in Biogen in Q4 2023 and has held it in 3 quarters since.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.